Results for tag: "Afrezza"

Afrezza is a drug used to treat diabetes, a metabolic disorder. It is an inhaled form of insulin, which is used to control blood sugar levels in people with type 1 and type 2 diabetes. Afrezza is a fast-acting insulin that is taken just before meals, and it helps to reduce the risk of hypoglycemia. It is also used to improve glycemic control in adults with type 2 diabetes. Afrezza is a relatively new drug, and it is gaining popularity among people with diabetes. It is a convenient and easy-to-use form of insulin, and it has been shown to be effective in controlling blood sugar levels. It is also a cost-effective option for people with diabetes, as it is less expensive than other forms of insulin. The Afrezza market is made up of several companies, including MannKind Corporation, Sanofi, and Novo Nordisk. These companies are involved in the development, manufacturing, and marketing of Afrezza. They are also involved in research and development of new treatments for diabetes. Show Less Read more